Telix Pharmaceuticals (AU: TLX)

Last close As at 26/04/2024

6.94

−0.20 (−2.80%)

Market capitalisation

1,979m

Edison Investment Research is terminating coverage on Telix Pharmaceuticals. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Share Price Performance

Financials

Edison Investment Research is terminating coverage on Telix Pharmaceuticals. Please note you should no longer rely on any previous research or estimates for these companies. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.